| Financial Year |
March 31 2023 |
| Monetary Funds |
544,429,191.23 |
| Held-for-trading Financial Assets |
240,000,000.00 |
| Notes Receivable |
6,310,875.88 |
| Accounts Receivable |
101,330,663.95 |
| Advances to Suppliers |
16,748,000.36 |
| Other Receivables |
8,313,244.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,434,402.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,656,461.47 |
| Total Current Assets |
1,098,799,336.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
48,914,445.37 |
| Investment Properties |
5,067,326.23 |
| Fixed Assetes |
525,203,265.43 |
| Under-construction Projects |
24,251,317.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,683,967.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
859,714.54 |
| Deferred Income Tax Assets |
4,890,038.48 |
| Other Non-Current Assets |
31,628,687.45 |
| Sub-Total of Non-Current Assets |
784,321,274.66 |
| Total Assets |
1,883,120,611.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,883,520.00 |
| Accounts Payable |
139,925,769.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,505,130.20 |
| Taxes Payable |
16,125,867.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,914,984.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,750,965.12 |
| Other Current Liabilities |
2,261,792.40 |
| Sub-Total of Current Liabilities |
280,560,245.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,146,178.36 |
| Deferred Income Tax Liabilities |
20,754,777.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
90,091,570.58 |
| Total Liabilities |
370,651,815.67 |
| Paid-In Capital(Or Share Stock) |
251,866,700.00 |
| Capital Surplus |
556,522,041.63 |
| Surplus Reserve |
76,446,010.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
616,025,806.72 |
| Minority Stockholder's Interest |
11,608,236.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,500,860,559.32 |
| Owner's Equity（Stockholder's Equity） |
1,512,468,795.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,883,120,611.18 |
